Skip navigation |

About Druglink

Welcome to Druglink

Druglink is a bi-monthly magazine for all those UK professionals interested in drugs and drug-related issues whether it's treatment, public health, education and prevention, criminal justice or international. Druglink includes the latest news, feature articles, interviews, factsheets, reviews and listings.

Latest issue: May/June 2013 28(3)

Druglink Cover May June 13.jpg

Since its introduction in mid-2011, the Department for Work and Pensions flagship Work Programme (WP) has come in for widespread criticism. In our free article this month, Paul Anders looks at the WP in detail, and considers its relevance for the drug and alcohol sector.

Please see a contents page for full details of this issue of Druglink.

Future issues

All future issues will be available online to DrugScope members only. Members will also be able to access two years of back copies.

For those of you who are simply subscribers, you have the option of switching to membership at the time when your current Druglink subscription expires. Note that in addition to Druglink, membership entitles you to discounts on publications and DrugScope events, access to the members area of this site and the opportunity to take part in DrugScope consultation exercises to put your views and concerns to government.

Free online issue!

This January-February 10 issue is free below. Please click the magazine to launch a full-size version in a reader (new window). You can browse the pages by clicking the white arrows at the sides of the reader.

Druglink International is also online

This is a pilot issue of Druglink International aimed at highlighting some of the unintended consequences of international drug policy, raising human rights issues and generally casting a spotlight on the international drug scene. Future issues are under discussion.

Please click the magazine below to launch a full-size version in a reader (new window). You can browse the pages by clicking the white arrows at the sides of the reader.

For more information please contact Harry Shapiro